Integrated DS-DP Manufacturing For Your Biologics

Built on the trust of our FDA & EMA-approved facilities. Powered by a $100 million investment. Designed for what's next.

Syngene's newest biologics manufacturing facility brings multiple lines, multiple products, and the largest single-use bioreactor capacity among Indian CDMOs — all under one roof.

From mAb to drug product in just 10 months. This is end-to-end biologics manufacturing, reimagined for scale and speed.